Antares Pharma, Inc. (NASDAQ: ATRS) today announced LEO Pharma's launch of OTREXUP to Dermatologists, the first U.S. Food and Drug Administration (FDA) approved subcutaneous (SC) methotrexate (MTX) ...
Please provide your email address to receive an email when new articles are posted on . A new self-administered methotrexate autoinjector had 90.5% subject usability, according to recently published ...
EWING, N.J., March 28, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced receipt of orphan drug designation to evaluate the use of subcutaneous methotrexate ("MTX") for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results